Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yangxue oral liquid
- Development stage
- Preclinical
- Lead developer
- Fenghuang Baiyunshan
- Administration
- Oral
01
Overview
Yangxue oral liquid, also known as YXKFY, is a Traditional Chinese Medicine (TCM) product developed by Hubei Fenghuang Baiyunshan Pharmaceutical Co., Ltd. It is an oral liquid composed of four traditional Chinese medicines: Melanteritum, Fructus Crataegi, Fructus Hippophae, and Ziziphus jujuba. It is being investigated for its neuroprotective effects, including antioxidant properties and addressing hypoxia-related features, in conditions such as Alzheimer's disease and Parkinson's disease. In TCM, it is used to nourish Qi and blood, particularly for patients with 'Qi and blood deficiency type'.
- Other names
- YangxueYXKFYnourishing blood oral liquid
Beyond the preview
Go deeper on Yangxue oral liquid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yangxue oral liquid.